These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 22288967)
21. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Demirci H; Eagle RC; Shields CL; Shields JA Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725 [TBL] [Abstract][Full Text] [Related]
23. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. Biswas J; Das D; Krishnakumar S; Shanmugam MP J Pediatr Ophthalmol Strabismus; 2003; 40(5):265-7. PubMed ID: 14560832 [TBL] [Abstract][Full Text] [Related]
24. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529 [TBL] [Abstract][Full Text] [Related]
25. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Eagle RC Arch Pathol Lab Med; 2009 Aug; 133(8):1203-9. PubMed ID: 19653710 [TBL] [Abstract][Full Text] [Related]
26. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness. Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119 [TBL] [Abstract][Full Text] [Related]
27. Histopathological features and P-glycoprotein expression in retinoblastoma. Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322 [TBL] [Abstract][Full Text] [Related]
28. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma]. Deng X; Cheng Y; Zhu XM; Linghu DD; Zhao MW; Liang JH Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):681-687. PubMed ID: 32907301 [No Abstract] [Full Text] [Related]
30. Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma. Chantada GL; Gonzalez A; Fandino A; de Davila MT; Demirdjian G; Scopinaro M; Abramson D J Pediatr Hematol Oncol; 2009 May; 31(5):325-9. PubMed ID: 19415010 [TBL] [Abstract][Full Text] [Related]
31. Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings. Bai S; Ren R; Shi J; Xu X; Zhao J; Gao F; Li L; Shen L; Li B; Jonas JB Br J Ophthalmol; 2011 Aug; 95(8):1072-6. PubMed ID: 20644215 [TBL] [Abstract][Full Text] [Related]
32. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972 [TBL] [Abstract][Full Text] [Related]
33. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country. Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727 [TBL] [Abstract][Full Text] [Related]
34. Associations among Socioeconomic Factors, Lag Time, and High-Risk Histopathologic Features in Eyes Primarily Enucleated for Retinoblastoma. Xiao W; Ye H; Zeng H; Tang L; Chen R; Gao Y; Mao Y; Yang H Curr Eye Res; 2019 Oct; 44(10):1144-1149. PubMed ID: 31173510 [No Abstract] [Full Text] [Related]
35. Retinoblastoma: Abnormal gadolinium enhancement of anterior segment of eyes at MR imaging with clinical and histopathologic correlation. Galluzzi P; Cerase A; Hadjistilianou T; De Francesco S; Toti P; Vallone IM; Filosomi G; Monti L; Bracco S; Gennari P; Ginanneschi C; Venturi C Radiology; 2003 Sep; 228(3):683-90. PubMed ID: 12881579 [TBL] [Abstract][Full Text] [Related]
36. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country. Suryawanshi P; Ramadwar M; Dikshit R; Kane SV; Kurkure P; Banavali S; Viswanathan S Arch Pathol Lab Med; 2011 Aug; 135(8):1017-23. PubMed ID: 21809993 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248 [TBL] [Abstract][Full Text] [Related]
38. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514 [TBL] [Abstract][Full Text] [Related]
39. [Histopathologic findings in retinoblastoma]. de Souza Filho JP; Martins MC; Torres VL; Dias AB; Lowen MS; Pires LA; Erwenne CM Arq Bras Oftalmol; 2005; 68(3):327-31. PubMed ID: 16059563 [TBL] [Abstract][Full Text] [Related]
40. Orbital recurrence of retinoblastoma following enucleation. Kim JW; Kathpalia V; Dunkel IJ; Wong RK; Riedel E; Abramson DH Br J Ophthalmol; 2009 Apr; 93(4):463-7. PubMed ID: 18757474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]